
MEI Pharma (Formerly Marshall Edwards)
Innovative oncology therapies targeting unmet medical needs in cancer treatment.
Market cap
$167m
Enterprise value
$129m
Share price
$5.20 MEIP
Authorizing premium user...
Innovative oncology therapies targeting unmet medical needs in cancer treatment.